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Abstract 
We here report an original approach to elucidate mechanisms of 
action of antimicrobial peptides and derive crucial structural 
requirements for the design of novel therapeutic agents. The high 
resolution structure of TB_KKG6A, an antimicrobial peptide 
designed to amplify the spectrum of action of Temporin B, bound 
to E. coli is here determined by means of CD and NMR 
methodologies. We have also defined, through STD analysis, the 
residues in closer proximity to the bacterial membrane.  
 
 
AMPs are produced by all organisms, eukaryotes and prokaryotes, 
either ribosomally or by multifunctional peptide synthetases1. 
The detailed mechanism by which AMPs work is far from being 
understood, although several hypotheses have been proposed2. 
AMPs can either target bacterial membranes or interact with the 
bacterial cytoplasmic content, causing the loss of vital function for 
bacteria and ultimately bacterial death. Partition constants calculated 
for AMPs suggest the higher affinity of peptides for bacterial vs 
mammalian membranes and also indicate that a very high local 
concentration of peptides on bacterial membranes is compatible with 
antibacterial activity3. The structures of AMPs have been so far 
derived only in presence of bacterial membrane model systems, such 
as  SDS and LPS.  It has been demonstrated that the three-
dimensional structure of peptides, obtained by solid state NMR in 
the presence of lipids mixtures, depends on the composition of the 
mixture4. Gain of details of the peptide interactions with intact 
cellular membranes, i.e. with whole bacterial cells, during the first 
stages of their activity represents a key step to fully understand their 
mechanism of action and derive crucial structural requirements for 
the design of novel therapeutic agents. Recent studies carried out by 
time-lapse fluorescence imaging studies on a melittin analogue with 
E. coli cells and synthetic membranes revealed a different behaviour 
of the peptide in the two different experimental systems5. Binding of 
the PMAP-23 peptide to E. coli cells has been investigated by 
fluorescence6. Structural studies of the AMPs magainin 2 and 
cecropin A by CD in the presence of E. coli cells and LPS have only 
recently been reported7; the results obtained in the two different 
experimental systems are comparable but not superimposable, likely 
  because of the different chemical composition of the two systems. 
Such studies allowed the determination of the peptide secondary 
structure in presence of cells but did not yield details at molecular 
level on the peptide three-dimensional arrangement. 
Recently we reported the design and characterization of 
TB_KKG6A
†8, a new analogue of  TB. TB is a member of the 
temporin family, ribosomally synthesized peptides, initially isolated 
from the skin of Rana temporaria that represents  the largest family 
of AMPs in amphibian (over 50 members)9. They are peptides 
composed of 8–14 amino acids amidated at the C-terminus and  
present a low net positive charge (from 0 to +3) at neutral pH. They 
are mainly active against Gram+ bacteria; few members of the 
temporin family, such as TL and T1DRa, efficiently kill Gram- 
bacteria but also show haemolytic activity10. 
Temporins, as most of the AMPs, do not show conformational 
preferences in aqueous buffers but, being highly membrane-active, 
have been hypothesized to fold upon interaction with bacterial 
membranes8, 11, 12, 13, 14. TA and TL assume helical conformation in 
SDS, DPC and LPS micelles12, 15, 16. Interestingly, the structure of 
TA and TL in SDS and DPC is monomeric, while in LPS both 
oligomerize in a head to tail fashion. NMR data on TB show that it 
does not fold in presence of LPS, likely because of self association. 
Combination of TB with sub-inhibitory concentrations of TL seems 
to prevent TB oligomerization on LPS, although the peptides are not 
at NMR measurable distances14, 17.  
The peptide TB_KKG6A contains one point mutation (G6A) within 
the TB sequence and two extra lysines at the N-terminus; it is active 
either against Gram+ and Gram- bacteria with a total lack of 
haemolytic activity. It is also able to down-regulate the expression of  
pro-inflammatory chemokines in IB3-1 cells infected with P. 
aeruginosa18. We showed via CD and NMR that, upon binding to 
  
 
LPS micelles, the peptide assumes a monomeric helical structure 
composed of two helical segments. The two extra Lys residues lies 
on the external surface of the LPS, anchoring the peptide to the 
bacterial membranes while Lys10 has a key role in penetrating the 
micelle8.  
Here, to gain structural details at the base of TB_KKG6A activity, 
we report the structural characterization via CD and NMR of 
TB_KKG6A bound to the Gram- bacterium E. coli. Experiments 
were carried out suspending cells respectively in phosphate buffer 
and in PBS as these conditions are compatible with the experimental 
measurements, and with E. coli survival7 (Supplementary Figure 
S1The cell viability was also evaluated  in the presence of 
TB_KKG6A in PBS (Supplementary Figure S1). The number of 
cells remained steady in the two first hours, but after this time cells 
lost their ability to duplicate when resuspended in LB 
The interaction of TB_KKG6A and of TB with E. coli was initially 
investigated by CD (Figure 1) as recently described7.  
 
 
 
 
 
Figure 1. CD spectra recorded at a 10M concentration of TB_KKG6A (Panels A and 
B) and TB (Panels C and D) incubated with E. coli cells (OD600 0.1) in phosphate 
buffer 10mM, pH7.0.Spectra shown are the results of the subtraction of the cell spectra 
to the cell+peptide mixture spectra. 
 
Time course experiments carried out in a 6 hours time span revealed 
that TB_KKG6A, which appears random coil and is likely in an 
oligomeric state in phosphate buffer (as suggested by NMR, see 
below), upon interaction with cells folds into a helix. The CD spectra 
reach the maximum intensity within 80 minutes of incubation and 
after this time, the intensity of the band around 224 nm tends to 
decrease.  
Time course experiments revealed that the peptide does not show 
conformational preferences when incubated with the cytoplasmic 
cell content obtained after sonication and centrifugation of bacteria, 
(Supplementary Figure S2) suggesting that the folding processes are 
induced by the bacterial outer membrane components.  
By contrast, TB, which in solution appears in a random 
conformation, in E. coli suspension remains mostly disordered (as 
observed also in the presence of the cells cytoplasmic content), 
although a little change in the position of minima appears after 40 
minutes of incubation with cells (Figure 1). Thus, TB either shows a 
very low affinity for bacteria or aggregates on E. coli cells or is 
trapped by the cell membrane, as hypothesized for another temporins 
member, TA, which is also inactive against Gram- bacteria.  
 
Sequence specific assignments of TB_KKG6A 1H chemical shifts 
(Table S1) and TB in the presence of E. coli were achieved 
analyzing 1H-1H TOCSY and 1H-1H NOESY spectra19 exploiting the 
previous reported assignments obtained for the monomeric peptide 
in presence of LPS8,15. Such chemical shifts do not change 
significantly in the presence of cells. Chemical shifts of both 
peptides assume typical random coil values along the entire 
sequence; nonetheless, while 2D tr-NOESY spectra of TB appear 
poor of cross-peaks, those of TB_KKG6A show a number of 
significant interresidues NOEs, indicating a cell-induced structural 
transition from random coil to a folded conformation.  
Accordingly, Dtrans measured on the peptide in presence of cells has 
a value of 1.49 ± 0.03 x 10-10 m2/s. The diffusion coefficient  
measured in the cell suspension is as expected slower than the one 
measured in simple water (ref 8) but faster than the one measured in 
PBS and ascribed to an aggregated form of the peptide. In fact, in 
buffer solution, the NMR spectra clearly indicate that TB_KKG6A is 
mostly aggregated (see SI); accordingly, in such conditions Dtrans 
(see Ref.6 in SI) yields a value of 0.83 ± 0.01 x 10-10 m2/s. 
Aggregation of the peptide in PBS was confirmed by DLS 
measurements, carried out for the peptide TBKK_G6A 
(Supplementary …) 
Overall, the DOSY and the chemical shift data are reasonably in 
agreement with a monomeric form of the peptide in a much more 
viscous environment. 
In presence of E. coli, TB_KKG6A residues of the Pro3–Ser11 
segment are characterized by strong short range HNi-HNi+1 and 
medium range NOEs, in particular HNi-HNi+2, Hi–HNi+3, and Hi–
Hi+3 correlations, typical of a helical conformation
19.  
.  
A total of 189 NOEs was obtained from tr-NOESY spectra of 
TB_KKG6A; these NOEs resulted in 143 meaningful distance (113 
inter-residues, 30 intra-residues) and 85 angle constraints which 
were used to generate a total of 100 structures, among which the 20 
with the lowest target function were selected and energy minimized. 
Noteworthy, all the recorded NOEs have been used to determine the 
monomeric structure of the peptide and no intermolecular NOE have 
been detected. The absence of long range NOEs connecting residues 
which are far apart in the structure suggests that the peptide when 
bound to E. coli membrane very likely does not undergo self-
association . 
 
The obtained structures satisfied the NMR constraints, with no 
violations greater than 0.2 Å (Table S2). The NMR structure of 
TB_KKG6A bound to E. coli is well defined as the RMSD for 
residues Pro3-Ser11 is 0.29Å and shows that the peptide folds in a 
regular helix, including two turns from Pro3 to Leu12 (Figure 2). 
 
 
 
 
 
 
 
 
  
  
 
  
 
 
 
 
 
 
 
 
Figure 2. Left. The side-chains orientation of a representative NMR structure of 
TB_KKG6A in presence of E. coli cells. Right. Sausage representation of NMR 
ensemble of structures of TB_KKG6A in presence of E. coli cells. 
 
 
 One side of the helix (Figure 3),contains  Pro3, Ala6 together with 
the two polar aminoacids (Asn7 and Ser12) and the positively 
charged Lys10 with its aliphatic chain. The other side of the helix is 
exclusively hydrophobic and constituted by Val5, Leu8, Leu9 and 
Leu12. Lys-2 and Lys-1 at the N-terminus, appear mostly structurally 
disordered, while Lys10 is more rigid and located on the second turn 
of the helix. This indicates that the relative positions of Lys10 and 
the two N-terminal lysines are not fixed, possibly because Lys-1 and 
Lys-2 form electrostatic interactions with phosphates of LPS chain 
protruding from the outer cellular leaflet. Concurrently, Lys10 is part 
of the helix surface, formed also by Pro3, Ala6 and Asn7 (Figure 4), 
directly interacting with the bacterial outer membrane. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Representation of the electrostatic surface potentials of TB_KKG6A bound to 
E. coli cells. The hydrophobic surfaces are colored in light gray, positively charged 
residues in blue. 
 
Modes of TB_KKG6A interaction with E. coli cells are confirmed 
by the STD20 in which  (Figure 4A) unambiguous STD effects could 
be assigned to Pro3, Ala6, Asn7 and Lys10.  
In particular, Pro3 Hs, Ala6 Hand Hs, Asn7 Hs and Lys10 H 
showed similar STD effects of about 50% (Figure 4B), suggesting 
their closer proximity to bacterial cell membranes. Differently, Lys-2 
and Lys-1 do not show STD effects.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. A: Superposition of the STD 1H-NMR spectrum and the reference 1H-NMR 
spectrum of TB_KKG6A in E. coli showing STD effects for side-chain protons. 
Unambiguous side-chain signals are assigned. B: Mapping onto a TB_KKG6A 
representative conformer of the residues that interact with the E. coli cell membrane. 
 
These data together with the CD results suggest a mechanism in 
which the disaggregation and folding processes of TB_KKG6A are 
induced by the bacterial outer membrane components. As other 
AMPs including polymixin B, pardaxin and MSI-59412,23 
TBKKG6A establishes with LPS strong interactions in a monomeric 
form. In other cases, as for TL, dimerization occurs to widen the 
peptide/LPS interaction surface. Peptides unable to kill Gram- 
bacteria either show very low affinity toward the LPS, as TB, or are 
trapped into it, as TA15,16.The peptide TB_KKG6A through Lys-1 
and Lys-2 amino groups anchors the negatively charged 
phospholipids and specifically binds to the bacterial membranes 
through Pro3, Ala6, Asn7 and Lys10 side chains. Pro3, and Ala6   
likely establish hydrophobic interactions with the bacterial 
membrane, analogously to what observed in presence of LPS 
micelles 8.  Lys10 side chain may either interact with the lipids of the 
membrane through  its long aliphatic chain, being inserted into the 
membrane, and/or may interact through the amino group with 
negatively charged phosphates. The presence of Lys10  on the same 
side of the helix of Pro3, Ala6, together with STD data suggesting a 
strong interaction between the side chain of Lys10 and the bacterial 
cells, is compatible with the formation of a disordered toroidal pore. 
Such structures have been hypothesized for melittin and magainin 
H2: in these peptides the charged residues were observed to point 
either into the pore or towards the water layer21,22.  
Accordingly, our recent characterization of TB_KKG6A in presence 
of LPS micelles8 also suggested that the augmented activity of this 
 
 
 
 
  
 
peptide could find an explanation in its ability to form strong 
interactions with LPS thanks to the increased positive charge at the 
N-terminus.  
Figure 5 reports the superposition of the two structures obtained in 
the two different systems, i.e. cellular context and LPS. While both 
systems induce the transition from a random coil to a helical 
structure, the two structure appear clearly different. In particular, in 
the presence of intact E. coli TB_KKG6A shows an uninterrupted 
helical segment while in presence of E. coli LPS folds into a kinked 
helix: a first helical segment encompasses residues Pro3 to Asn7, 
followed by a kink including residue Leu8 and by a second helical 
region from residue Leu9 to Ser11.. As it is shown clearly in Figure 
5, Pro3, Ala6 and Asn 7 side chains, involved in the interaction with 
LPS and the intact E,Coli membrane, assume very similar 
orientations in  the two environments. Differently, Lys10 side chain, 
which in LPS adopts two main different orientations, in cellular 
environment assume a single preferred conformations, significantly 
different from those observed in LPS. These structural features 
support the hypothesis that Lys10 may play a major role in the 
membrame permeation and indicate that the data obtained in LPS, 
that represent a valuable model tool to mimic the bacterial 
membrane, can be profitably complemented by structural data 
obtained in the presence of cells. 
 
The data here presented supply extra detailed structural information 
about peptide-cellular membrane interactions. The results confirm 
the identity of the residues responsible for the  interactions with 
outer leaflet and underline how the presence of concentrated positive 
charges is pivotal to the activity against Gram- bacteria. These 
results are further supported by literature data, showing that natural 
and also synthetic peptides with exposed positive charges, as 
protegrins and most of peptides/proteins possessing a gamma core 
motif23, are highly active against Gram- bacteria.  
 
 
Conclusions 
In the present study, we have determined, by means of CD and 
NMR methodologies applied in cellular environments, the high 
resolution structure of an antimicrobial peptide, designed to 
amplify the spectrum of action of TB, bound to Gram- E. coli 
membrane. We have also defined, through STD analysis, the 
peptide surface in closer proximity to the outer membrane. 
These data provide the high resolution molecular details of an 
AMP directly bound to the bacterial cells, complementing our 
recent structural characterization of TB_KKG6A in the 
presence of LPS membrane model system. In particular, the 
presence of a positively charged patch seems to be required to 
increase the affinity of AMPs toward Gram- bacterial cells; 
furthermore the lack of a marked amphipaticity helps to prevent 
the aggregation of the peptide on cell membrane.   
 
Notes  
†TB_KKG6A sequence = K-2K-1LLPIVA6NLLKSLL 
Abbrevations: AMP = Antimicrobial peptide; TA = Temporin-1a; TB = 
Temporin-1b; TL = Temporin L; T1DRa = Temporin 1DRa; Gram+ = 
Gram positive; Gram- = Gram negative; DPC = Dodecylphosphocholine; 
SDS = Sodium dodecyl sulfate; LPS = Lipopolysaccharide,is the main 
component of the Gram- bacteria outer leaflet and therefore it is 
considered a reliable model system for bacterial membranes; CD = 
Circular dichroism; NMR = Nuclear magnetic resonance; STD = 
Saturation Transfer difference; NOE = Nuclear Overhauser Effect; Dtrans = 
Translational Diffusion Coefficient; RMSD = Root Mean Square 
Deviation. 
 
Methods 
For methods see Supporting Information. 
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